Pfiz­er CEO Al­bert Bourla says com­pa­ny crossed safe­ty mile­stone for Covid-19 vac­cine, EUA sub­mis­sion im­mi­nent

Pfiz­er won’t say when they’ll send their Covid-19 vac­cine to the FDA, ex­cept that it’s go­ing to be very soon.

Speak­ing at New York Times and STAT sum­mits Tues­day, CEO Al­bert Bourla said that, in their Phase III tri­al with BioN­Tech, they have al­ready passed the min­i­mum two-month fol­low-up the agency re­quires that de­vel­op­ers reach to ob­tain emer­gency use au­tho­riza­tion. With news last week that an in­ter­im analy­sis showed the vac­cine was “over 90% ef­fec­tive,” that would ap­pear to give the Big Phar­ma and their biotech part­ner most of the da­ta re­quired to achieve the first US OK for a Covid-19 vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER